Safety profile of biologic therapy in Polish paediatric patients with Crohn's disease

INTRODUCTION: In recent years, monoclonal antibodies against tumor necrosis factor α (TNF-α), infliximab (IFX), and adalimumab (ADA) have gained increasing popularity in Crohn's disease (CD) management. Many clinical trials have shown that biologics are a generally well-tolerated and safe treat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Prz Gastroenterol
Autors principals: Szymanska, Edyta, Dadalski, Maciej, Oracz, Grzegorz, Kierkus, Jarosław
Format: Artigo
Idioma:Inglês
Publicat: Termedia Publishing House 2015
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4607696/
https://ncbi.nlm.nih.gov/pubmed/26516383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pg.2015.52298
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars